TikTok, liver cancer and Rachel Yaffe
TikToker Rachel Yaffe dies of rare liver cancer at 27
The TikToker was first diagnosed with fibrolamellar carcinoma cancer when she was 20 years old and amassed over 55,000 followers as she began to share updates on her health journe
TikTok Star Rachel Yaffe Said She 'Lost So Much of My Strength' in Final Cancer Update Before Her Death at 27
Over one month before her death at age 27, TikTok star Rachel Yaffe made a video explaining how a recent radiation treatment for her stage 4 liver cancer affected her physical and mental health.
TikTok star Rachel Yaffe dead at 27 after liver cancer battle
TikTok star Rachel Yaffe died Friday, exactly a month before her 28th birthday, following a years-long battle with a rare form of liver cancer.
TikToker Rachel Yaffe Dead at 27 After Battle With Liver Cancer
TikToker Rachel Yaffe, known for her wellness and lifestyle content, has died after a liver cancer battle. She was 27.
TikTok Star Rachel Yaffe Dies at 27 After Being Diagnosed with Rare Liver Cancer
TikTok star Rachel Yaffe has died at age 27 after several years of living with a rare liver cancer.
TikToker Documenting Her Rare Cancer Battle Dies at 27
Rachel Yaffe, a TikToker known for sharing her life as she battled cancer, has died at 27. TMZ reported on Wednesday that an obituary confirmed her death on Oct. 11. In her years-long battle with fibrolamellar hepatocellular carcinoma,
TikToker Rachel Yaffe Dies at 27 After Battling Liver Cancer
After fighting liver cancer for seven years, TikToker Rachel Yaffe has passed away at the age of 27. She made a heartfelt post before her passing. The post TikToker Rachel Yaffe Dies at 27 After Battling Liver Cancer appeared first on Instafamosos.
Mourning a fighter: TikToker Rachel Yaffe succumbs to rare cancer
American social media is in mourning. This is due to news from the family of Rachel Yaffe, a TikToker who battled a rare liver cancer for seven years. Her family announced that her fight against cancer had ended.
TikToker Rachel Yaffe dies of liver cancer
Rachel Yaffe, a 27-year-old TikTok star with a rare form of liver cancer, has died. Per her obituary, Yaffe passed away on Oct. 11, leaving behind her parents, brother and sister. The TikToker was first diagnosed with fibrolamellar carcinoma cancer when she was 20 years old and amassed over 55,
Biomarker may predict immunotherapy response in liver cancer
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...
News Medical on MSN1h
Study identifies biomarkers for immunotherapy success in liver cancer
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...
NKyTribune14h
In many cases, liver cancer is preventable; here are steps you can take to reduce the risk
By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...
health.economictimes.indiatimes12h
Learn about liver cancer
https://gco.iarc.who.int/media/globocan/factsheets/populations/356-india-fact-sheet.pdf ...
News Medical2h
New grant aims to transform treatment for liver cancer
Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...
Verywell Health on MSN1h
How Liver Fibrosis Develops and Is Treated
Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...
ThePrint2h
Study: Biomarker may predict response to immunotherapy in liver cancer
According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may ...
YOUR HEALTH: HAI therapy: Game changer for colon cancer patients
Hepatic artery infusion delivers chemo directly into the liver, and that increases the survival rate by up to 40 percent.